Document Type
Article
Publication Date
11-30-2020
Keywords
JMG
JAX Source
Sci Rep 2020 Nov 30; 10(1):20848
Volume
10
Issue
1
First Page
20848
Last Page
20848
ISSN
2045-2322
PMID
33257774
DOI
https://doi.org/10.1038/s41598-020-77632-8
Grant
HG000330; OD020351; AA18776
Abstract
The emergence of the SARS-CoV-2 virus and subsequent COVID-19 pandemic initiated intense research into the mechanisms of action for this virus. It was quickly noted that COVID-19 presents more seriously in conjunction with other human disease conditions such as hypertension, diabetes, and lung diseases. We conducted a bioinformatics analysis of COVID-19 comorbidity-associated gene sets, identifying genes and pathways shared among the comorbidities, and evaluated current knowledge about these genes and pathways as related to current information about SARS-CoV-2 infection. We performed our analysis using GeneWeaver (GW), Reactome, and several biomedical ontologies to represent and compare common COVID-19 comorbidities. Phenotypic analysis of shared genes revealed significant enrichment for immune system phenotypes and for cardiovascular-related phenotypes, which might point to alleles and phenotypes in mouse models that could be evaluated for clues to COVID-19 severity. Through pathway analysis, we identified enriched pathways shared by comorbidity datasets and datasets associated with SARS-CoV-2 infection.
Recommended Citation
Dolan ME,
Hill DP,
Mukherjee G,
McAndrews M,
Chesler E,
Blake JA.
Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease. Sci Rep 2020 Nov 30; 10(1):20848
Comments
The authors would like to thank Dr. Peter D’Eustachio and Dr. Laurens Wilming for their critical reading of the manuscript.
This article is licensed under a Creative Commons Attribution 4.0 International License.